GR67605B - - Google Patents
Info
- Publication number
- GR67605B GR67605B GR61749A GR800161749A GR67605B GR 67605 B GR67605 B GR 67605B GR 61749 A GR61749 A GR 61749A GR 800161749 A GR800161749 A GR 800161749A GR 67605 B GR67605 B GR 67605B
- Authority
- GR
- Greece
- Prior art keywords
- general formula
- signifies
- compound
- see diagramm
- formula see
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229940091173 hydantoin Drugs 0.000 abstract 1
- -1 hydantoin compound Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 150000002461 imidazolidines Chemical class 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000001301 oxygen Chemical group 0.000 abstract 1
- 229910052760 oxygen Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Epoxy Resins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH383779 | 1979-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR67605B true GR67605B (en, 2012) | 1981-08-31 |
Family
ID=4264536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR61749A GR67605B (en, 2012) | 1979-04-24 | 1980-04-22 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0017976B1 (en, 2012) |
| JP (1) | JPS55143974A (en, 2012) |
| KR (1) | KR850000719B1 (en, 2012) |
| AT (1) | ATE3860T1 (en, 2012) |
| CA (1) | CA1135706A (en, 2012) |
| DE (1) | DE3063837D1 (en, 2012) |
| DK (1) | DK174480A (en, 2012) |
| ES (1) | ES8104243A1 (en, 2012) |
| FI (1) | FI801184A7 (en, 2012) |
| GR (1) | GR67605B (en, 2012) |
| HU (1) | HU184271B (en, 2012) |
| NO (1) | NO801182L (en, 2012) |
| PT (1) | PT71135B (en, 2012) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5411981A (en) * | 1991-01-09 | 1995-05-02 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
| USRE35956E (en) * | 1991-01-09 | 1998-11-10 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
| FR2715402B1 (fr) * | 1994-01-05 | 1996-10-04 | Roussel Uclaf | Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
| FR2724169B1 (fr) * | 1994-09-06 | 1997-01-03 | Roussel Uclaf | Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| TW521073B (en) * | 1994-01-05 | 2003-02-21 | Hoechst Marion Roussel Inc | New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them |
| DE602004031881D1 (de) | 2003-12-19 | 2011-04-28 | Univ California | Verfahren und materialien zur beurteilung von prostatakrebstherapien |
| WO2005099693A2 (en) | 2004-02-24 | 2005-10-27 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies and compounds |
| US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
| FI2004181T6 (fi) | 2006-03-27 | 2023-09-01 | Androgeenireseptorin modulaattori eturauhassyövän ja androgeenireseptoriin liittyvien sairauksien hoitamiseksi | |
| EP2439196A1 (en) * | 2006-03-29 | 2012-04-11 | The Regents of The University of California | Diarylthiohydantoin compounds for use in a method for the treatment of a hyperproliferative disorder |
| CA2703635C (en) | 2007-10-26 | 2017-06-27 | Michael E. Jung | Diarylhydantoin compounds as androgen receptor modulators |
| BR112012020558B1 (pt) | 2010-02-16 | 2020-11-03 | Aragon Pharmaceuticals, Inc | moduladores do receptor de androgênio, suas composições farmacêuticas, e seus usos |
| DK3305285T3 (da) | 2012-09-26 | 2020-10-26 | Aragon Pharmaceuticals Inc | Anti-androgener til behandlingen af ikke-metastatisk kastrationsresistent prostatakræft |
| JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
| TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
| KR20200070334A (ko) | 2017-10-16 | 2020-06-17 | 아라곤 파마슈티컬스, 인코포레이티드 | 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB997037A (en) * | 1962-03-19 | 1965-06-30 | Ici Ltd | New hydrantoin derivatives |
| US3340070A (en) * | 1963-08-23 | 1967-09-05 | Shell Oil Co | Artificial sweetening agent |
| FR2329276A1 (fr) * | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
| MC1220A1 (fr) * | 1977-10-28 | 1979-07-20 | Hoffmann La Roche | Nouveaux derives d'imidazolidine |
| IL55774A (en) * | 1977-10-28 | 1982-04-30 | Sparamedica Ag | Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture |
-
1980
- 1980-04-14 FI FI801184A patent/FI801184A7/fi not_active Application Discontinuation
- 1980-04-16 EP EP80102042A patent/EP0017976B1/de not_active Expired
- 1980-04-16 DE DE8080102042T patent/DE3063837D1/de not_active Expired
- 1980-04-16 AT AT80102042T patent/ATE3860T1/de not_active IP Right Cessation
- 1980-04-18 CA CA000350162A patent/CA1135706A/en not_active Expired
- 1980-04-21 JP JP5180480A patent/JPS55143974A/ja active Pending
- 1980-04-22 GR GR61749A patent/GR67605B/el unknown
- 1980-04-23 NO NO801182A patent/NO801182L/no unknown
- 1980-04-23 PT PT71135A patent/PT71135B/pt unknown
- 1980-04-23 ES ES490799A patent/ES8104243A1/es not_active Expired
- 1980-04-23 DK DK174480A patent/DK174480A/da not_active Application Discontinuation
- 1980-04-23 HU HU80995A patent/HU184271B/hu unknown
- 1980-04-24 KR KR1019800001691A patent/KR850000719B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI801184A7 (fi) | 1981-01-01 |
| ES490799A0 (es) | 1981-04-16 |
| PT71135B (en) | 1981-08-07 |
| HU184271B (en) | 1984-07-30 |
| KR830002722A (ko) | 1983-05-30 |
| EP0017976A3 (en) | 1981-04-01 |
| CA1135706A (en) | 1982-11-16 |
| EP0017976B1 (de) | 1983-06-22 |
| DK174480A (da) | 1980-10-25 |
| DE3063837D1 (en) | 1983-07-28 |
| JPS55143974A (en) | 1980-11-10 |
| PT71135A (en) | 1980-05-01 |
| ATE3860T1 (de) | 1983-07-15 |
| ES8104243A1 (es) | 1981-04-16 |
| EP0017976A2 (de) | 1980-10-29 |
| KR850000719B1 (ko) | 1985-05-23 |
| NO801182L (no) | 1980-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR67605B (en, 2012) | ||
| BG38639A3 (en) | Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid | |
| BG41993A3 (en) | Means and method for increase in cold resistance of plant cultures | |
| AU1395283A (en) | 1-carboxyalkanoylindoline-2-carboxylic acid esters | |
| GR77088B (en, 2012) | ||
| HU179545B (en) | Compositions for plant growth regulation containing phthalamide acid | |
| MY101645A (en) | Phosphoric esters and process for preparing the same. | |
| GB1394007A (en) | Sulphoximines | |
| FR2479813B1 (en, 2012) | ||
| HU9300423D0 (en) | Method for producing amino-methane-phosphonic acid and amino-methane-phosphinic one | |
| ES8308870A1 (es) | Procedimiento para la preparacion de derivados de acido 5-(4-fenil-1-piperidinil) metil-2,3-dihidro-2-oxo-1h-imidazol-4-carboxilico. | |
| GB1276277A (en) | 2-chloroethane-(thiono)-phosphonic acid amido compounds, processes for their preparation, and their use for the regulation of plant growth | |
| FR2457275B1 (en, 2012) | ||
| AU567867B2 (en) | 5(e)-13,14,18,18,19,19-hexahydro-6a-carbaprostaglandin 12 derivatives | |
| ES8605529A1 (es) | Procedimiento para la preparacion de acidos alfa-aminoal- quilfosfonicos y de acidos alfa-aminoalquilfosfinicos | |
| IE44403L (en) | CIS-4a-PHENYL-ISOQUINOLINES | |
| PL218562A1 (en, 2012) | ||
| SE7701107L (sv) | Biologiskt aktiva amider | |
| CA1273347C (en, 2012) | ||
| LU88287I2 (fr) | Cyproternacetate (Climen) | |
| DE3264330D1 (en) | Process for the preparation of cycloalkenon derivatives | |
| GB1526607A (en) | Zearalin ethers | |
| ES461718A1 (es) | Procedimiento para la obtencion de composiciones herbicidas | |
| EP0041576A4 (en) | 1- (2,6-DICHLORPHENYL) -2-QUINOLINONE-IMIN-3-CARBOXYLIC ACID, PRODUCTION OF THE COMPOUND AND CONTAINING PAIN-RELIEFING, ANTI-FLAMMING COMPOSITION. | |
| ES461037A1 (es) | Un procedimiento para la preparacion de derivados tiofeno. |